About Pallav Shah
Professor Pallav Shah, Consultant Physician, currently works within the Royal Brompton Hospital NHS Trust and sees private patients at One Welbeck.
Professor Shah began his medical training at Guy's Hospital Medical School, graduating in 1989. He then went on to do specialist respiratory medicine training at several hospitals in London - the Royal Brompton Hospital, St Mary's Hospital, and Chelsea and Westminster Hospital. He has now had over 25 years working as a consultant physician.
Professor Shah remains dedicated to improving his patients care, he can do so by advising on the boards of national and global guideline groups and most importantly holding the position of specialist adviser to NICE. Additionally, he was a member of the Cardiovascular, Diabetes, Renal, Respiratory and Allergy Expert Advisory Group working for the Commission on Human Medicines. This group advises the government on the suitability, safety, and efficacy of medicines and medicinal products.
Professor Shah is active in both the research and the development of new treatments. He has developed several novel therapies; which include endobronchial valves, endobronchial coils, Vapor and Aeriseal sealant for emphysema, lung denervation for COPD, liquid nitrogen cryospray and pulsed electrical field therapy for chronic bronchitis, and bronchial thermoplasty for asthma. He was the first to perform robotic bronchoscopy in the UK with the Ion Robotic system. He is currently developing robotic guided ablation of lung tumours.
He has over 300 publications and several books – including his contribution as sectional editor of the thoracic section of Grays Anatomy (39th & 40th editions) and as sectional editor for respiratory section of the Oxford textbook of Medicine (6th edition). He also the author of an Atlas of Flexible Bronchoscopy and chief editor of Essentials of Clinical Pulmonology. He is a fellow of the European Respiratory Society.
Expertise
- COPD
- Emphysema
- Asthma
- Bronchoscopy
- EBUS and Lung Cancer Screening
Overview
- Age of patients seen
- 18+
- Languages spoken
- English
- Online profiles
- Research highlights
Key Publications:
Khalil K, Agbontaen K, McNally D, Love A, Mandalia S, Banya W, Starren E, Dhunnookchand R, Farne H, Morton R, Davies G, Orhan O, Lai D, Nelson M, Shah PL, Garner JL. Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital. J Infect
. 2020 Jun 18:S0163-4453(20)30408-4. doi: 10.1016/j.jinf.2020.06.027.
van Geffen WH, Slebos DJ, Herth FJ, Kemp SV, Weder W, Shah PL. Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis. Lancet Respir Med
. 2019 Feb 7. pii: S2213-2600(18)30431-4. doi: 10.1016/S2213-2600(18)30431-4. [Epub ahead of print].
Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth FJ, Shah PL. Predictors of Response to Endobronchial Coil Therapy in Patients with Advanced Emphysema. Chest. 2019 Feb 21. pii: S0012-3692(19)30188-6. doi: 10.1016/j.chest.2019.02.012. [Epub ahead of print]
Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N Jr, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ; LIBERATE Study Group. A Multicenter RCT of Zephyr® Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198:1151-1164.
Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, Deslée G, Tillis WP, Delage A, Marquette CH, Krishna G, Kalhan R, Ferguson JS, Jantz M, Maldonado F, McKenna R, Majid A, Rai N, Gay S, Dransfield MT, Angel L, Maxfield R, Herth FJ, Wahidi MM, Mehta A, Slebos DJ; RENEW Study Research Group. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial. JAMA. 2016; 315: 2178-89.
Herth FJF, Valipour A, Shah PL, Eberhardt RC, Egan J, Ficker JH, Wagner M, Witt C, Liebers U, Hopkins P, Gesierich W, Phillips M, Stanzel F, McNulty WH, Petermann C, Snell G, Gomplemann D. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. The Lancet Respir Med 2016; 4:185-93.
Davey C, Zoumot Z, Jordan S, McNulty WH, Carr DH, Hind MD, Hansell DM, Rubens MB, Banya W, Polkey MI, Shah PL, Hopkinson NS. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015. 386:1066-1073
Herth FJ, Eberhardt R, Sterman D, Silvestri GA, Hoffmann H, Shah PL. Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules. Thorax. 2015;70:326-332.
Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quirring J, Hopkinson NS, Kemp SV. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013;1:233-40.
Shah PL, Slebos, DJ. Cardoso PFG, Cetti E, Voelker K, Levine B, Rusell ME, Goldin J, Brown M, Cooper JG, Sybrecht GW, on behalf of the EASE trial study group. Bronchoscopic lung volume reduction with exhale airway stents for emphysema (EASE trial): randomised, sham-controlled multicentre trial. Lancet 2011 Sept;378:997-1005.
- Professional memberships
British Thoracic Society
International Association for the Study of Lung Cancer
Royal College of Physicians
World Association of Bronchology & Bronch-Oesophalagy
- Certifications and Awards
May 2003: FRCP (UK)
Oct 2019: FERS (Fellow of the European Respiratory Society)
August 2013 onwards Associate Editor for “Respiration”
March 2018 Royal College of Physicians Edinburgh Gold Medal
Consultations and services
- Self-pay available from £350
- Health insurance
- 15 mins consultation
- Self-pay available from £280
- Health insurance
- 15 mins consultation
Insurers covered
Tests & treatments
Conditions & symptoms
Locations
Loading
Frequently asked questions
Yes, but only for certain services. Some consultations, assessments, and treatments can be booked directly, while others require a GP or specialist referral. Please check the relevant service page for guidance, and contact the centre if you’re unsure.
We aim to offer appointments as quickly as possible, and many services have same-day or next-day availability. Waiting times vary depending on the appointment type, specialty, and consultant availability, but our team will always offer the earliest suitable appointment.
Yes. You can arrange an appointment for a family member, or someone you care for, just let us know when you get in touch. We’ll need their details and consent to complete the booking, unless you're their legal guardian or have power of attorney.
Your first consultation includes a detailed discussion of your symptoms, medical history, and lifestyle factors, followed by a thorough examination. It’s helpful if you can bring the results of any previous investigations with you, as well as a list of your current medications. Come with a comfortably full bladder so you can provide a urine sample if requested.